Celularity Inc. (CELU) Earnings History
Annual and quarterly earnings data from 2018 to 2024
Loading earnings history...
CELU EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
CELU Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 72.4% | -70.7% | -106.8% |
| 2023 | 29.7% | -844.4% | -862.0% |
| 2022 | -9.4% | -142.4% | 79.0% |
| 2021 | 54.8% | -511.2% | -469.3% |
| 2020 | 65.5% | -1064.0% | -1458.4% |
Download Data
Export CELU earnings history in CSV or JSON format
Free sign-in required to download data
Celularity Inc. (CELU) Earnings Overview
As of May 8, 2026, Celularity Inc. (CELU) reported trailing twelve-month net income of -$81M, reflecting +76.0% year-over-year growth. The company earned $-3.06 per diluted share over the past four quarters, with a net profit margin of -106.8%.
Looking at the long-term picture, CELU's historical earnings data spans multiple years. The company achieved its highest annual net income of $14M in fiscal 2022.
Celularity Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including FATE (-$136M net income, -2051.1% margin), NKTR (-$164M net income, -297.1% margin), SANA (-$234M net income), CELU has outperformed on profitability metrics. Compare CELU vs FATE →
CELU Earnings vs Peers
Earnings metrics vs comparable public companies
CELU Historical Earnings Data (2018–2024)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$58M | +70.5% | -$38M | $-2.64 | -106.8% | -70.7% |
| 2023 | -$196M | -1483.1% | -$192M | $-11.02 | -862.0% | -844.4% |
| 2022 | $14M | +114.2% | -$26M | $0.95 | 79.0% | -142.4% |
| 2021 | -$100M | +51.9% | -$109M | $-14.93 | -469.3% | -511.2% |
| 2020 | -$208M | +1.7% | -$152M | $-113.06 | -1458.4% | -1064.0% |
| 2019 | -$212M | -19296894.5% | -$264M | $-88.75 | -1001.9% | -1249.0% |
| 2018 | $-1,098 | - | $-1,098 | $0.00 | -0.0% | -0.0% |
See CELU's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CELU Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CELU vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCELU — Frequently Asked Questions
Quick answers to the most common questions about buying CELU stock.
Is CELU growing earnings?
CELU EPS is $-3.06, with earnings growth accelerating to +76.0%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-81M.
What are CELU's profit margins?
Celularity Inc. net margin is -106.8%, with operating margin at -70.7%. Below-average margins reflect competitive or cost pressures.
How consistent are CELU's earnings?
CELU earnings data spans 2018-2024. The accelerating earnings trend is +76.0% YoY. Historical data enables comparison across business cycles.